Ionis earnings call
Web11 apr. 2024 · Ionis Pharmaceuticals (IONS) In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Ionis Pharmaceuticals, with a price target of $42.00 . The company’s shares ... Web9 nov. 2024 · EPS of -$0.16 beats by $0.37 Revenue of $160.00M (20.30% Y/Y) beats by $14.33M Ionis Pharmaceuticals, Inc. ( NASDAQ: IONS) Q3 2024 Earnings Conference …
Ionis earnings call
Did you know?
Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00. Web4 mei 2024 · On track to achieve 2024 financial guidance. Webcast today, May 4, 2024, at 11:30 a.m. Eastern Time CARLSBAD, Calif., May 4, 2024 /PRNewswire/ -- Ionis …
Web3 nov. 2024 · Other Ticker Details IONS Company Name Ionis Pharmaceuticals, inc Earnings Call Date 3-Nov-2024 Time (ET) 11:30 AM Fiscal Quarter Q3 Fiscal Year Web10 apr. 2024 · Ionis Pharmaceuticals, Inc. has a 12 month low of $31.46 and a 12 month high of $48.82. The stock has a market cap of $5.33 billion, a price-to-earnings ratio of -19.62 and a beta of 0.54. The company has a current ratio of 7.07, a quick ratio of 7.00 and a debt-to-equity ratio of 2.06. Ionis Pharmaceuticals ( NASDAQ:IONS - Get Rating) last ...
WebAll news about IONIS PHARMACEUTICALS, INC. Morgan Stanley Adjusts Price Target on Ionis Pharmaceuticals to $42 From $40, Maintains.. Transcript : Ionis Pharmaceuticals, … WebThe company held a conference call for investors at 11:30 AM eastern on the same day. IONS shares declined -3.7% the day following the earnings announcement to close at …
Web(AKCA) latest earnings report: revenue, EPS, surprise, history, news and analysis. Date of report (Date of earliest event reported): August 30, 2024. 34, delivering a surprise of -72. apr. 30-07-2024 Stocks Analysis by Zacks Investment Research covering. 0 million to Ionis as a sublicense fee. 49 on 08/04/20; Next Earnings Date 11/03/20.
WebSupport: 888-992-3836 Home NewsWire Subscriptions ... good morning monster中文Web2 dagen geleden · DUBLIN, April 11, 2024 /PRNewswire/ -- The "Global Alzheimer's Therapeutics Market (2024-2027) by Diagnostics, Drug Class, Distribution, and Geography, Competitive Analysis and the Impact of Covid ... good morning monster lauraWeb11 apr. 2024 · Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Equal-Weight and raises the price target from $40 to $42. good morning monster reviewWebIonis Pharmaceuticals, Inc. (IONS) Q4 2024 Earnings Call Transcript by seekingalpha.com - 02-22 Good morning, and welcome to Ionis Pharmaceuticals Fourth Quarter and Full Year 2024 Financial Results Conference Call. [Operator Instructions]. As a reminder, this call is being recorded. Ionis Pharmaceuticals: Q4 Earnings Snapshot by wtop.com - 02-22 good morning monster peterWeb26 okt. 2024 · 26 October 2024, 10:01 am · 5-min read. Wall Street expects a year-over-year decline in earnings on higher revenues when Ionis Pharmaceuticals (IONS) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact … good morning monster by catherine gildinerWeb22 feb. 2024 · Ionis Pharmaceuticals, Inc. ( NASDAQ: IONS) Q4 2024 Results Conference Call February 22, 2024 11:30 AM ET Company Participants Wade Walke - SVP, IR Brett … chessmaster software for windows 10 pcWebInvestors & Media NASDAQ: BMRN $93.41 $5.67 (6.46%) Currency in USD.Quote data delayed by at least 15 minutes. Transforming Lives Through Genetic Discovery We seek to make a big difference in genetic disorders. chess master torrent